Post by Merck

Name: Today at #ASCO26, we’re sharing five-year follow-up data from a Phase 2b trial evaluating our invest
Uploaded: 2026-06-01T12:23:40.791Z
Channel: Merck
Description: Today at #ASCO26, we’re sharing five-year follow-up data from a Phase 2b trial evaluating our investigational individualized neoantigen therapy for #melanoma in collaboration with Moderna. This work r

2,739,412 followers

Today at #ASCO26, we’re sharing five-year follow-up data from a Phase 2b trial evaluating our investigational individualized neoantigen therapy for #melanoma in collaboration with Moderna. This work reflects our continued efforts to advance personalized approaches to cancer research. Learn more: https://go.merck.com/~nws

Video Content